Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 7;2(1):e000241.
doi: 10.1136/bmjmed-2022-000241. eCollection 2023.

New and emerging treatments for myasthenia gravis

Mckenzye DeHart-McCoyle  1 , Shital Patel  2 , Xinli Du  1
Affiliations

New and emerging treatments for myasthenia gravis

Mckenzye DeHart-McCoyle et al. BMJ Med. .
No abstract available

Keywords: Drug therapy; Immunology; Neurology; Neuromuscular diseases.

PubMed Disclaimer

Conflict of interest statement

Competing interests: We have read and understood the BMJ policy on declaration of interests and declare the following interests: none.

Figures

Figure 1
Figure 1
Illustration of antibody mediated pathogenesis in myasthenia gravis. Ab=antibody; ACh=acetylcholine; AChR=acetylcholine receptor; MAC=membrane attack complex; MuSK=muscle specific tyrosine kinase
Figure 2
Figure 2
Illustration of sites of action targeted by emerging and current treatments for myasthenia gravis
See this image and copyright information in PMC

References

    1. Vincent A, Newsom-Davis J. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays. J Neurol Neurosurg Psychiatry 1985;48:1246–52. 10.1136/jnnp.48.12.1246 - DOI - PMC - PubMed
    1. Dresser L, Wlodarski R, Rezania K, et al. . Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations. J Clin Med 2021;10:2235. 10.3390/jcm10112235 - DOI - PMC - PubMed
    1. Sussman J, Farrugia ME, Maddison P, et al. . The Association of British Neurologists' myasthenia gravis guidelines. Ann N Y Acad Sci 2018;1412:166–9. 10.1111/nyas.13503 - DOI - PubMed
    1. Narayanaswami P, Sanders DB, Wolfe G, et al. . International consensus guidance for management of myasthenia gravis: 2020 update. Neurology 2021;96:114–22. 10.1212/WNL.0000000000011124 - DOI - PMC - PubMed
    1. Suh J, Goldstein JM, Nowak RJ. Clinical characteristics of refractory myasthenia gravis patients. Yale J Biol Med 2013;86:255–60. - PMC - PubMed

LinkOut - more resources